California State University  (CSU) Chancellor's Office

CSU to Implement COVID-19 Vaccination Requirement Upon FDA Approval

Requirement would go into effect for the fall 2021 term contingent upon one or more vaccines receiving full approval

Newswise — (April 22, 2021) – In the interest of maintaining the health and safety of students, employees, guests and all members of campus communities, the California State University (CSU) joined the University of California (UC) today (April 22, 2021) in announcing that the universities intend to require faculty, staff and students who are accessing campus facilities at any university location to be immunized against SARS-CoV-2, the virus that causes COVID-19. This requirement will be conditioned upon full approval of one or more vaccines by the U.S. Food and Drug Administration (FDA), as well as adequate availability of the fully approved vaccines. This requirement will become effective at the beginning of the fall 2021 term, or upon full FDA approval of the vaccine, whichever occurs later. 

“Together, the CSU and UC enroll and employ more than one million students and employees across 33 major university campuses, so this is the most comprehensive and consequential university plan for COVID-19 vaccines in the country,” said CSU Chancellor Joseph I. Castro. “Consistent with previous CSU announcements related to the university’s response to the pandemic, we are sharing this information now to give students, their families and our employees ample time to make plans to be vaccinated prior to the start of the fall term.”

“Receiving a vaccine for the virus that causes COVID-19 is a key step people can take to protect themselves, their friends and family, and our campus communities while helping bring the pandemic to an end,” said UC President Michael V. Drake, M.D.

Prior to the implementation of any changes to the CSU’s existing immunization requirements, the CSU will engage the California State Student Association, the CSU Academic Senate and labor unions. The COVID-19 vaccination requirement would allow for students or employees to seek an exemption based on medical or religious grounds. The policy and related implementation details are under development and will be made available once the consultations have concluded.

“The state of California has been a leader in the administration of COVID-19 vaccines, and Californians receiving a vaccine has led to significantly reducing the transmission of COVID-19 in our state,” added Castro. “Continued vigilance will further mitigate the spread of the disease that has radically altered our lives over the past year. We will continue to strongly encourage all members of our respective university communities to receive a COVID-19 vaccination as soon as it is available to them.”

As announced in December 2020, the CSU plans for the majority of instruction and activities in fall 2021 to be in-person while acknowledging there will be variance across the campuses. The planned COVID-19 vaccine requirement will further enable the campuses to be repopulated.

 

About the California State University The California State University is the largest system of four-year higher education in the country, with 23 campuses, 56,000 faculty and staff and 486,000 students. Half of the CSU's students transfer from California community colleges. Created in 1960, the mission of the CSU is to provide high-quality, affordable education to meet the ever-changing needs of California. With its commitment to quality, opportunity and student success, the CSU is renowned for superb teaching, innovative research and for producing job-ready graduates. Each year, the CSU awards nearly 129,000 degrees. One in every 20 Americans holding a college degree is a graduate of the CSU and our alumni are 3.9 million strong. Connect with and learn more about the CSU in the CSU NewsCenter. 



Filters close

Showing results

110 of 5870
Released: 24-Jun-2021 12:30 PM EDT
A tecnologia de IA e ECG pode descartar rapidamente a infecção por COVID-19, concluiu o estudo da Mayo Clinic
Mayo Clinic

A inteligência artificial (IA) pode oferecer uma maneira de determinar com precisão se uma pessoa não está infectada com a COVID-19. Um estudo retrospectivo internacional descobriu que a infecção pelo SARS-CoV-2, o vírus que causa a COVID-19, cria mudanças elétricas sutis no coração. Um eletrocardiograma (ECG) habilitado com IA pode detectar essas alterações e, potencialmente, ser usado como um teste de triagem rápido e confiável para descartar a infecção por COVID-19.

Released: 24-Jun-2021 12:10 PM EDT
妙佑医疗国际(Mayo Clinic)的研究发现,AI赋能的心电图技术有可能迅速排除COVID-19感染
Mayo Clinic

AI (人工智能)有可能提供准确判断一个人未感染COVID-19(2019冠状病毒病)的方法。一项国际回顾性研究发现,如果感染了导致COVID-19的SARS-CoV-2病毒,患者的心脏会产生微妙的电学变化。AI赋能的心电图(EKG)可以检测到这些变化,并有望被用于进行快速、可靠的COVID-19筛查检测,以排除COVID-19感染。

Newswise: 200421_Felgner_3205_sz-2-768x496.jpg
Released: 24-Jun-2021 11:50 AM EDT
UCI Professor Wins Spain’s Prestigious Princess of Asturias Award for Scientific Research
University of California, Irvine

Irvine, Calif., June 24, 2021 — Philip Felgner, Ph.D., professor in residence of physiology & biophysics at the University of California, Irvine, is one of seven scholars worldwide to win Spain’s prestigious Princess of Asturias Award for Technical and Scientific Research in recognition of their contributions to designing COVID-19 vaccines.

Released: 24-Jun-2021 11:00 AM EDT
New protein engineering method could accelerate the discovery of COVID-19 therapeutics
University of Michigan

Discovering and engineering nanobodies with properties suitable for treating human diseases ranging from cancer to COVID-19 is a time-consuming, laborious process.

Newswise: Decoding humans’ survival from coronaviruses
Released: 24-Jun-2021 11:00 AM EDT
Decoding humans’ survival from coronaviruses
University of Adelaide

An international team of researchers co-led by the University of Adelaide and the University of Arizona has analysed the genomes of more than 2,500 modern humans from 26 worldwide populations, to better understand how humans have adapted to historical coronavirus outbreaks.

access_time Embargo lifts in 2 days
Embargo will expire: 29-Jun-2021 4:00 PM EDT Released to reporters: 24-Jun-2021 10:35 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Jun-2021 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: COVIDLockdownSimulations.jpg
Released: 24-Jun-2021 10:00 AM EDT
Pandemic Air Quality Affected By Weather, Not Just Lockdowns
Washington University in St. Louis

Using a diverse set of tools, the lab of Randall Martin shows how the pandemic did – or didn’t – affect levels of particulate matter during COVID lockdowns.

Released: 24-Jun-2021 6:05 AM EDT
Longest known SARS-CoV-2 infection of nearly 300 days successfully treated with new therapy
University of Bristol

An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been successfully treated with two investigational monoclonal antibodies (laboratory engineered antibodies). Clinicians and researchers from the University of Bristol and North Bristol NHS Trust (NBT) worked closely to assess and treat the infection and want to highlight the urgent need for improved access to treatments for such people with persistent SARS-CoV-2 infection.

Released: 23-Jun-2021 3:55 PM EDT
Cooperative Extension grant aims to vaccinate NYS’ vulnerable
Cornell University

A two-year, $200,000 grant from the USDA and the Extension Foundation to Cornell University researchers aims to help promote vaccine confidence and uptake in vulnerable communities in eight New York counties, both upstate and downstate.

Released: 23-Jun-2021 12:10 PM EDT
Phone swabs can accurately detect COVID-19
University College London

An accurate, non-invasive, and low-cost method of testing for COVID-19 using samples taken from the screens of mobile phones has been developed by a team led by UCL researchers at Diagnosis Biotech.


Showing results

110 of 5870

close
1.15382